OA
PFE icon

Oasis Advisors’s Pfizer PFE Stock Holding History

Oasis Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,825
Closed -$922K – 181
2026
Q1 		$922K Buy
+32,825
New +$874K 0.18% 80

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Oasis Advisors's PFE Position: Q2 2026 in Review

Oasis Advisors sold out of Pfizer (PFE) in Q2 2026, closing a stake of 32,825 shares — an estimated $922K sold.

Oasis Advisors first reported a position in PFE in Q1 2026 and held it in 1 quarter. The position peaked at $922K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Oasis Advisors reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Oasis Advisors sold 32,825 Pfizer shares in Q2 2026, an estimated $922K.
  • Oasis Advisors first reported a position in Pfizer in Q1 2026 and held it in 1 quarter.
  • Oasis Advisors's Pfizer position peaked at $922K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Oasis Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.